{"id":509634,"date":"2026-06-25T01:05:08","date_gmt":"2026-06-25T01:05:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/509634\/"},"modified":"2026-06-25T01:05:08","modified_gmt":"2026-06-25T01:05:08","slug":"innovents-partner-ollin-biosciences-announces-oversubscribed-330-million-series-b-financing-to-advance-global-phase-3-development-of-ibi324-oln324-in-dme-and-wet-amd-studies-commencing-in-se","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/509634\/","title":{"rendered":"Innovent&#039;s Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second Half of 2026 &#8211; PR Newswire"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi-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?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Innovent&#8217;s Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second Half of 2026<\/a>&nbsp;&nbsp;PR Newswire<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiggFBVV95cUxOUmoxeE1vQjl0NVMycVN2amRlTXR2MDhkQTFNVmJxcDZEaUx1NTZETTVibElORWpfSzNTb09QZy1XMl9Tb3c5UDlWV0tlcWZ5NG5CSExHUlc4ZUZiWDVwMk9JYTFyOUxXNU9nbW0wbzY0Rk5wMG1hWGRxUGlWRTdjeW9R?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Ophthalmology venture grabs investors\u2019 attention, raises $330 million<\/a>&nbsp;&nbsp;statnews.com<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMimgFBVV95cUxNVldvQXFKOTVQNHRDalZKN3p1M1V0bE11NnpRdzE2eXlSa1kzNF9xd1daOFZIUElnRlpyM09zVzRLUWlmT29rdG42cUtaSmlRdDFDeGhkX09VbmE2YzRnMzBYRmdudFZjVUVVbkx4Mll5UVUzZzFLSEZsSU5KcDlMWW1HUFJqUjdycnVzMGNfUHlXOENKTElfV213?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Ollin nets $330M to run Phase 3 trials of Vabysmo challenger from China<\/a>&nbsp;&nbsp;Endpoints News<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi3wJBVV95cUxPRWxtYjM0ODNpOXJnT0tOTkVmTUFIcG16QjYyb1pzNGMtaHdMczEwZ2gtY3BkZHlLc25CY0sxSXBUSnNtWVd5WGkxWnJVY2ZDak1tVExfdjJod0Z6Tm9nYi1iZDcwTEhsYXNQaURfRUliRk5PYkNMd2JoRjlaenlaaGw5aWdoSWFkTzM5Y1dfNmRwRXdRRHBpcnFqc3ZMeWVNVVhZQmxnOWtvY0lmWEtaN2VGZXlhRDBkeG11N28tYUdqQVNwdmFPajJSX2hzdzJNSXFHazN3NVlJMlYyVUw2OERsMU9BdmYybnJPX2sxME1qTHRKNWxzY1RNNVpHVnBFTlpaQ0tMRFNDYXMwakJxOHFZTVhfMENPcnlDNkdwYkJOOXoxV0YtU1RGQ3J6NmNwU1NHSC1Va2FjdVlieXFXbGxFb0ZpU3k5cWh5WjdOWGJXTy12VjdwYmt4SHlXMGs?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026<\/a>&nbsp;&nbsp;Business Wire<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMirgFBVV95cUxOME9QR3NjM3hHYmdjYmpLZlh3NVFXRkF5c2dSYy1OSGpkYnVSckxLQm5HeXd6MUp4Q2NwS3ZXaU9zUWpwYnRrUlo1ZDJjMktnSkM0THBxZnRaUGNSVmNEVHVZSEFLRTlCVDFIYWxQeExoZWszRDE4bEdmWGpnWnc1dXJWRnU5T1ZUcWdoZjBTaVRPcnZrXzZkNnpXQkR6d0I5U2lTZWNDRWl1eUc2ZlE?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Ollin hauls in $330M to enlist Vabysmo challenger in phase 3 eye disease gauntlet<\/a>&nbsp;&nbsp;Fierce Biotech<\/p>\n","protected":false},"excerpt":{"rendered":"Innovent&#8217;s Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of&hellip;\n","protected":false},"author":2,"featured_media":419076,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[114,85,46],"class_list":["post-509634","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/509634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=509634"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/509634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/419076"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=509634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=509634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=509634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}